Researchers Link Use of GLP-1 Medications to Lower Risk of Violence A Rutgers study finds that treatments such as Ozempic and Wegovy may diminish the link between impulsivity and violent behavior The use of GLP-1 medications commonly prescribed for weight loss or managing diabetes may have effects that extend beyond metabolic health, including on behaviors linked to violence, according to Rutgers researchers
In comparison, without insurance coverage Wegovy, Novo Nordisks semaglutide product that has been approved for weight loss, has a list price of approximate $1,350 per month
Off-target effects can pose risks, such as tumor development or immune responses
DHA-Licensed Medical Providers Patients should consider receiving treatment only from DHA-licensed clinics and qualified healthcare professionals
Our social environments, stressful lives, and to a large degree, our cultural acceptance of alcohol all stand in the way of cutting down or removing it from our lives altogether
& Kim, S